PHATHOM PHARMACEUTICALS, INC. (PHAT) Operating income 2018–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual operating income history from SEC filings — each fiscal year as reported.
-$160.0MFY2025 · since FY2018: -$1.2M → -$160.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.0M | +42.3% |
| FY2024 | -$277.5M | -65.8% |
| FY2023 | -$167.3M | +3.0% |
| FY2022 | -$172.4M | -27.7% |
| FY2021 | -$135.1M | -7.5% |
| FY2020 | -$125.7M | -18.3% |
| FY2019 | -$106.2M | -8570.6% |
| FY2018 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice